| Literature DB >> 11700578 |
C Lass-Flörl1, M P Dierich, D Fuchs, E Semenitz, M Ledochowski.
Abstract
Three patients with premenstrual dysphoric disorder (PMDD) and recurrent vulvovaginal candidiasis (VVC) underwent sertraline therapy (Tresleen, a selective serotonin-reuptake inhibitor; Pfizer) for PMDD. During sertraline intervention, patients had no recurrent episodes of acute VVC. Antifungal activity was observed for sertraline against various isolates of Candida species.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11700578 DOI: 10.1086/324589
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079